Publications of the Cell Based Drug Development Section

Showing results 1 - 10 out of 37

2024


Almeria C, Weiss R, Keck M, Weber V, Kasper C, Egger D. Dynamic cultivation of human mesenchymal stem/stromal cells for the production of extracellular vesicles in a 3D bioreactor system. Biotechnology letters. 2024 Apr;46(2):279–293. Epub 2024 Feb 13. doi: 10.1007/s10529-024-03465-4
Egger D, Baier L, Moldaschl J, Taschner M, Lorber V, Kasper C. Development of a novel high-throughput culture system for hypoxic 3D hydrogel cell culture. Scientific reports. 2024 Apr 30;14(1):9904. doi: 10.1038/s41598-024-60822-z
Nikolits I, Chariyev-Prinz F, Egger D, Liebner F, Mytzka N, Kasper C. Characterization of MSC Growth, Differentiation, and EV Production in CNF Hydrogels Under Static and Dynamic Cultures in Hypoxic and Normoxic Conditions. Bioengineering. 2024 Oct 21;11(10):1050. doi: 10.3390/bioengineering11101050

2023


Egger D, Nebel S, Gensler M, Kreß S, Hansmann J, Kasper C. Bioreactors: enabling technologies for research and manufacturing. In De Boer J, Van Blitterswijk CA, editors, Tissue Engineering. 3 ed. Elsevier. 2023. p. 431-456 doi: 10.1016/B978-0-12-824459-3.00013-5
García Aponte OF, Kozma B, Egger D, Kasper C, Herwig C. Kinetics of NK-92 growth and functionality in pseudo-static cultures. Biochemical engineering journal. 2023 Jul;196:108929. Epub 2023 Jul 13. doi: 10.1016/j.bej.2023.108929
Nikolits I, Radwan S, Liebner F, Dietrich W, Egger D, Chariyev-Prinz F et al. Hydrogels from TEMPO-Oxidized Nanofibrillated Cellulose Support In Vitro Cultivation of Encapsulated Human Mesenchymal Stem Cells. ACS Applied Bio Materials. 2023 Feb 20;6(2):543-551. Epub 2023 Feb 6. doi: 10.1021/acsabm.2c00854

2022


Almeria C, Kreß S, Weber V, Egger D, Kasper C. Heterogeneity of mesenchymal stem cell-derived extracellular vesicles is highly impacted by the tissue/cell source and culture conditions. Cell and Bioscience. 2022 May 2;12(1):51. doi: 10.1186/s13578-022-00786-7
Egger D, Hansmann J, Kasper C, Kouroupis D. Editorial: Advanced cell culture technologies to boost cell-based therapies, volume II. Frontiers in Bioengineering and Biotechnology. 2022 Aug 30;10:999765. doi: 10.3389/fbioe.2022.999765
Egger D, Lavrentieva A, Kugelmeier P, Kasper C. Physiologic isolation and expansion of human mesenchymal stem/stromal cells for manufacturing of cell-based therapy products. Engineering in Life Sciences. 2022 Mar 28;22(3-4):361-372. doi: 10.1002/elsc.202100097
Hohenwallner K, Troppmair N, Panzenboeck L, Kasper C, El Abiead Y, Koellensperger G et al. Decoding Distinct Ganglioside Patterns of Native and Differentiated Mesenchymal Stem Cells by a Novel Glycolipidomics Profiling Strategy. Journal of the American Chemical Society. 2022 Nov 28;2(11):2466-2480. Epub 2022 Nov 25. doi: 10.1021/jacsau.2c00230